SCHEMBL22988960

SCHEMBL22988960

c1ccc(-c2nc(-c3ccccc3)nc(-c3cccc4c(-n5c6ccc7cccc8oc9cccc%10ccc5c(c%109)c6c78)cccc34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.36
TSHR P16473 5/20 0.36
SMN1; SMN2 Q16637 3/20 0.36
TDP1 Q9NUW8 2/20 0.36
MAPK1 P28482 2/20 0.36
HSD17B10 Q99714 2/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
TP53 P04637 1/20 0.36
HPGD P15428 1/20 0.36
NFKB1 P19838 1/20 0.36
NFKB2 Q00653 1/20 0.36
RELA Q04206 1/20 0.36
ATM Q13315 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TERT O14746 2/20 0.32
ABCG2 Q9UNQ0 2/20 0.32
PDE6D O43924 1/20 0.32
ADORA3 P0DMS8 1/20 0.32
ALOX15 P16050 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22988909 0.90 ALOX5 (0.35) MAPTTSHRSMN1; SMN2TDP1MAPK1
SCHEMBL22988606 0.88 KDM4E (0.33) MAPTTSHRSMN1; SMN2TDP1MAPK1
SCHEMBL22988956 0.87 SIRT2 (0.33) MAPTTSHRSMN1; SMN2TDP1HSD17B10
SCHEMBL24266855 0.87 KDM4E (0.30) MAPTTSHRSMN1; SMN2TDP1MAPK1
SCHEMBL17178535 0.86 ALDH1A1 (0.40) MAPTTSHRSMN1; SMN2TDP1MAPK1
SCHEMBL24154016 0.85 TSHR (0.36) MAPTTSHRSMN1; SMN2TDP1MAPK1
SCHEMBL22988982 0.85 TSHR (0.38) MAPTTSHRMAPK1HSD17B10KDM4E
SCHEMBL22257555 0.85 KDM4E (0.32) MAPTTSHRSMN1; SMN2TDP1MAPK1
SCHEMBL22988973 0.85 TDP1 (0.33) MAPTTSHRSMN1; SMN2TDP1MAPK1
SCHEMBL22988914 0.84 PRKDC (0.33) MAPTTDP1KDM4EALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021029757-A1 NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING SAME 주식회사 엘지화학 2021-02-18 WO disclosed
US-20160340361-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 AUSPEX PHARMACEUTICALS, INC. 2016-11-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160340361-A1 PIPERIDINE INHIBITORS OF JANUS KINASE 3 JAK2, JAK3, PAK3 MAPT 2964/4885TSHR 3548/4885SMN1; SMN2 4257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.